INSMED Inc - Common Stock, par value $0.01 per share (INSM)

Historical Holders from Q1 2014 to Q3 2025

Symbol
INSM on Nasdaq
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
211M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
211M
Holdings value
$30.3B
% of all portfolios
0.036%
Grand Portfolio weight change
+0.001%
Number of holders
556
Number of buys
314
Number of sells
-268
Average Value change %
-0.01%
Average buys %
+0.004%
Average sells %
-0.014%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INSMED Inc - Common Stock, par value $0.01 per share (INSM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JPMORGAN CHASE & CO 10.8% +36.3% $2.83B $964M 23M +51.8% JPMORGAN CHASE & CO. 29 Aug 2025
Darwin Global Management, Ltd. 9.7% +13.3% $2.95B $729M 20.5M +32.9% Darwin Global Management, Ltd. 30 Sep 2025
VANGUARD GROUP INC 10.18% $1.26B 18.2M The Vanguard Group 31 Dec 2024
BlackRock, Inc. 5.1% $979M 9.73M BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.3% -43.3% $998M -$619M 6.93M -38.3% T. Rowe Price Associates, Inc. 30 Sep 2025

Institutional Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 211M $30.3B +$445M $144.01 556
2025 Q2 210M $21.1B +$1.36B $100.64 513
2025 Q1 198M $15.1B +$439M $76.29 436
2024 Q4 193M $13.3B +$245M $69.04 434
2024 Q3 188M $13.7B +$901M $73.00 411
2024 Q2 175M $11.7B +$1.77B $67.00 375
2024 Q1 150M $4.06B -$1.1M $27.13 284
2023 Q4 150M $4.64B +$24.7M $30.99 269
2023 Q3 147M $3.72B +$69M $25.25 249
2023 Q2 146M $3.09B +$30.2M $21.10 221
2023 Q1 145M $2.48B +$29.2M $17.05 229
2022 Q4 144M $2.87B +$305M $19.98 224
2022 Q3 128M $2.75B -$213M $21.54 229
2022 Q2 129M $2.55B +$40.3M $19.72 200
2022 Q1 126M $2.97B +$75.1M $23.50 211
2021 Q4 123M $3.36B -$21.5M $27.24 201
2021 Q3 123M $3.4B +$40.5M $27.54 184
2021 Q2 121M $3.46B +$431M $28.46 194
2021 Q1 107M $3.63B -$6.65M $34.06 194
2020 Q4 108M $3.58B -$44.4M $33.29 202
2020 Q3 109M $3.5B -$57M $32.14 195
2020 Q2 111M $3.05B +$375M $27.54 183
2020 Q1 97.6M $1.56B -$41.2M $16.03 159
2019 Q4 98.3M $2.35B -$38.9M $23.88 169
2019 Q3 99M $1.75B -$518M $17.64 153
2019 Q2 126M $3.24B +$1.15B $25.60 165
2019 Q1 82.2M $2.39B -$1.13M $29.07 151
2018 Q4 82.4M $1.08B -$9.48M $13.12 120
2018 Q3 80.9M $1.64B -$43.6M $20.22 120
2018 Q2 82.4M $1.95B +$16.7M $23.65 125
2018 Q1 81.8M $1.84B +$128M $22.52 125
2017 Q4 75.9M $2.37B +$39.1M $31.18 125
2017 Q3 73.7M $2.3B +$549M $31.21 142
2017 Q2 56.5M $970M +$39.9M $17.16 110
2017 Q1 57M $998M +$70M $17.51 97
2016 Q4 57.8M $765M +$2.35M $13.23 96
2016 Q3 57.5M $834M +$19.1M $14.52 93
2016 Q2 56.5M $557M -$8.09M $9.86 103
2016 Q1 57M $722M -$13M $12.67 97
2015 Q4 56.9M $1.03B -$19.9K $18.15 111
2015 Q3 56.8M $1.05B +$35.5M $18.57 117
2015 Q2 54.4M $1.33B +$21.9M $24.42 115
2015 Q1 53.7M $1.12B +$261M $20.80 117
2014 Q4 41.9M $649M +$11.2M $15.47 94
2014 Q3 41.3M $539M +$115M $13.05 99
2014 Q2 31M $619M +$3.35M $19.98 102
2014 Q1 30.2M $573M +$41.5M $19.04 108